Fluticasone Propionate API

Holiness Pharmaceutical Ltd is a trusted and leading supplier, exporter and manufacturer of Fluticasone Propionate API, delivering high-quality corticosteroid APIs to pharmaceutical companies across 40+ international markets. Fluticasone Propionate is a potent topical and inhaled corticosteroid widely used in the treatment of asthma, allergic rhinitis, COPD, and dermatological inflammatory conditions, positioning us as a reliable Fluticasone Propionate bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Fluticasone Propionate API manufacturers, offering high assay purity, controlled impurity profile, low residual solvents, and excellent stability suitable for inhalation, nasal spray, and topical formulations. Our expertise in corticosteroid synthesis makes us a dependable Pharmaceutical API exporter.

Our advanced corticosteroid API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, tight impurity control, micronization capability, and full pharmacopeial compliance for Fluticasone Propionate API.

We export Fluticasone Propionate API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting manufacturers producing inhalers, nasal sprays, creams, and respiratory therapies. Holiness Pharmaceutical is widely trusted as a bulk Fluticasone Propionate API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, corticosteroid synthesis, commercial-scale manufacturing, quality assurance, and global distribution.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.